Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SSX family member 6, pseudogene (SSX6P) is a genomic locus that has high sequence similarity to SSX genes implicated in synovial sarcoma, but lacks regulatory elements and is not believed to encode a functional protein. Pseudogenes such as SSX6P are evolutionary remnants that may occasionally be transcribed into RNA and rarely translated into short peptides, though most have no known biological function or disease role. The SSX protein family, but not their pseudogenes, is relevant in cancer biology and immune response[1][2][3]. Experimentally, distinguishing SSX pseudogenes and their respective functional genes is difficult due to high sequence conservation, complicating genetic and transcriptomic analyses. Most pseudogenes are considered non-targets for drug development and clinical applications[2][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SSX family member 6, pseudogene (SSX6P).